查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949647

高壓造影注射器市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、類型、應用、最終用途、地區和競爭格局分類），2021-2031年

High Pressure Contrast Media Injectors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球高壓造影注射器市場預計將從 2025 年的 2.8235 億美元成長到 2031 年的 4.3236 億美元，複合年成長率達到 7.36%。

這些專用設備旨在將造影劑精確輸送到血管內，從而改善電腦斷層掃描 (CT)、磁振造影(MRI) 和血管造影術等診斷程序中的組織顯像效果。市場成長的主要驅動力是全球慢性疾病（例如心血管疾病和癌症）發病率的上升，這些疾病需要頻繁且準確的診斷影像才能有效管理。此外，全球人口老化也持續推高了對這些重要治療方法的需求。為了強調這項需求，美國癌症協會在 2024 年預測，到 2050 年，全球癌症負擔可能達到每年約 3,500 萬例新增病例，凸顯了對可擴展診斷影像能力的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 2.8235億美元
市場規模：2031年 4.3236億美元
複合年成長率：2026-2031年 7.36%
成長最快的細分市場 噴油嘴系統
最大的市場 北美洲

然而，市場擴張的一大障礙是與實施和營運先進注射器系統相關的高昂成本。這些自動化設備的高昂價格，加上耗材的持續成本，給醫療預算帶來了沉重負擔，尤其是在報銷有限的發展中地區。這種經濟壓力會阻礙高性能注射器技術的廣泛應用，常常迫使注重成本的醫療機構依賴效率較低的手動給藥技術。

市場促進因素

全球範圍內電腦斷層掃描 (CT) 和磁振造影(MRI) 檢查數量的不斷成長是推動市場發展的主要因素。隨著醫療機構致力於提高複雜疾病診斷的準確性，對橫斷面影像的需求激增，直接增加了對可靠造影輸送系統的需求。這一趨勢在近期統計數據中得到了體現。根據英國國家醫療服務體系 (NHS England) 於 2024 年 11 月發布的《2023/24 年度診斷影像資料集統計》，CT 檢查數量年增 8.4%，達到 770 萬例；MRI 檢查數量年增 8.1%，達到 440 萬例。日益成長的工作量迫使醫療機構投資於高通量輸液設備，以加快患者周轉速度。此外，西門子醫療在 2024 年 11 月發布的「2024 年第四季財務業績」中報告稱，其影像部門的銷售額同比成長 7.7%，表明全球對診斷基礎設施的投資持續成長。

輸液設備系統的技術創新，促進了自動化和更智慧的操作，也推動了市場成長。製造商正致力於開發可與放射資訊系統 (RIS) 整合的設備，以自動追蹤藥物劑量並最大限度地減少造影劑浪費，從而提高營運效率。主要產業參與者的大量研發投入支持了向智慧生態系統的轉變。例如，GE醫療於2024年2月發布的2023年度報告重點介紹了其超過10億美元的研發投資，旨在加速精準醫療和平台標準化。這些投資正在推動具有個人化劑量設定和即時監測功能的智慧注射器的開發，鼓勵醫療機構從傳統硬體升級到可簡化臨床工作流程的先進連網設備。

市場挑戰

高壓造影輸液設備的高昂實施和營運成本是限制市場成長的一大障礙。這些系統需要大量的初始投資，而且通常還需要持續投入資金購買注射器和輸液管等專用耗材。對於小規模的醫療機構和醫療報銷政策嚴格的地區的醫院而言，這種雙重經濟負擔尤其沉重。因此，面臨有限資本投資預算的管理者往往選擇維持現有的手動通訊協定，而不是升級到自動化系統。

這些經濟壓力有效地減緩了整個產業對新技術的採用。美國醫院協會 (AHA) 預測，到 2024 年，醫院總支出將年增約 6%，這將進一步減少可用於購買非必需醫療設備的財務空間。這些預算限制迫使採購部門優先考慮必要的營運成本，而非新的診斷設備。這種財務狀況限制了輸液設備的銷售量，並阻礙了其在價格敏感地區的市場滲透率提升。

市場趨勢

關鍵市場趨勢包括注重環保和減少廢棄物的組件設計，這源自於醫療保健產業減少環境足跡和管理供應鏈風險的需求。製造商正在加速從傳統的一次性系統向先進的無針和多患者耗材工作流程的過渡。這項轉變旨在顯著減少醫療塑膠廢棄物，並最大限度地減少未使用的造影劑，從而應對環境挑戰和供不應求。這項永續性措施正成為一項競爭標桿，Bracco 的《2024 年永續發展報告》重點介紹了公司負責任的生產實踐，使其榮獲 EcoVadis 白金獎，並躋身全球永續企業前 1%，這印證了該行業對綠色技術的日益重視。

同時，人工智慧演算法的整合正在將注射器從簡單的給藥裝置轉變為互聯的智慧診斷節點。這一趨勢不僅限於基本的連接，還將深度學習模型直接融入成像生態系統，從而在不影響診斷品質的前提下增強影像重建並減少造影造影用量。這項技術演進得益於商業環境的支持，軟體改進的價值與硬體本身不相上下。近期的數據也印證了這一數位轉型的規模。根據拜耳公司2024年12月發布的「RSNA 2024」新聞稿，2023年全球醫療影像人工智慧收入將超過7.34億美元，這顯示現代造影給藥系統所依賴的數位基礎設施正在迅速擴展，以最佳化臨床療效。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 高壓造影注射器的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（輸液系統、耗材、注射器、導管等）
    • 依類型（單頭注射器、雙頭注射器、無針注射器）
    • 依應用領域（介入性心臟病學、介入性放射學、血管內外科、介入性神經放射學）
    • 依最終用途（醫院、診斷中心、門診手術中心）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美高壓造影注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲高壓造影注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區高壓造影注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲高壓造影注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲高壓造影注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球高壓造影注射器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Bracco SpA
  • Guerbet AG（Guerbet Group）
  • Medtron AG
  • GE HealthCare Technologies Inc.
  • Bayer Healthcare LLC
  • NemotoKyorindo Co., Ltd
  • ulrich GmbH & Co. Kg
  • Sino Medical-Device Technology Co., Ltd.
  • APOLLO RT Co. Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25356

The Global High Pressure Contrast Media Injectors Market is projected to expand from USD 282.35 Million in 2025 to USD 432.36 Million by 2031, achieving a CAGR of 7.36%. These specialized devices are engineered to precisely deliver radiopaque contrast agents into the vascular system, thereby improving tissue visualization during diagnostic procedures like Computed Tomography, Magnetic Resonance Imaging, and angiography. Market growth is largely driven by the rising global incidence of chronic conditions, such as cardiovascular diseases and cancer, which require frequent and accurate diagnostic imaging for effective management. Furthermore, the aging global population continues to sustain the demand for these essential interventions. Highlighting this need, the American Cancer Society projected in 2024 that the global cancer burden could reach approximately 35 million new cases annually by 2050, emphasizing the urgent requirement for scalable imaging capacities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 282.35 Million
Market Size 2031USD 432.36 Million
CAGR 2026-20317.36%
Fastest Growing SegmentInjector Systems
Largest MarketNorth America

However, a major obstacle to market expansion is the significant cost associated with acquiring and operating advanced injector systems. The high price of these automated units, combined with the ongoing expense of single-use consumables, exerts considerable pressure on healthcare budgets, especially in developing regions with limited reimbursement frameworks. This financial strain can hinder the widespread adoption of high-performance injector technology, often compelling cost-sensitive facilities to depend on less efficient manual administration techniques.

Market Driver

The increasing global volume of Computed Tomography and Magnetic Resonance Imaging procedures serves as a primary catalyst for the market. As healthcare providers aim to enhance diagnostic precision for complex conditions, the demand for cross-sectional imaging has surged, directly heightening the need for reliable contrast delivery systems. This trend is reflected in recent statistics; according to NHS England's November 2024 'Diagnostic Imaging Dataset Annual Statistical Release 2023/24', the number of CT scans rose by 8.4% to 7.7 million, and MRI scans increased by 8.1% to 4.4 million compared to the prior year. This growing workload drives facilities to invest in high-throughput injectors capable of handling rapid patient turnover. Furthermore, Siemens Healthineers reported a 7.7% comparable revenue growth in its Imaging segment in the November 2024 'Q4 Fiscal Year 2024' earnings release, indicating sustained global investment in diagnostic infrastructure.

Technological advancements in automated and smart injector systems also significantly drive market growth. Manufacturers are increasingly focusing on devices that integrate with Radiology Information Systems to automate dosage tracking and minimize contrast waste, thereby improving operational efficiency. This move toward intelligent ecosystems is backed by substantial R&D investments from key industry players. For instance, GE HealthCare's February 2024 '2023 Annual Report' highlighted an investment of over $1 billion in research and development to accelerate precision care and standardize platforms. Such funding facilitates the creation of smart injectors with personalized dosing and real-time monitoring capabilities, encouraging healthcare facilities to upgrade from legacy hardware to sophisticated, connected units that streamline clinical workflows.

Market Challenge

The high acquisition and operational costs associated with high-pressure contrast media injectors constitute a significant barrier to market growth. These systems require a substantial initial capital investment, which is often compounded by the recurring expense of proprietary consumables like syringes and tubing sets. This dual financial burden poses a particular challenge for smaller healthcare facilities and hospitals in regions with restrictive reimbursement policies. Consequently, when faced with limited capital expenditure budgets, administrators frequently choose to maintain existing manual protocols rather than upgrading to automated systems.

These economic pressures effectively decelerate the adoption of new technology across the sector. The American Hospital Association projected in 2024 that total hospital expenses would rise by nearly 6 percent compared to the previous year, further tightening the financial margins available for discretionary medical equipment purchases. Such budgetary constraints force procurement departments to favor essential operational costs over new diagnostic machinery. This financial climate suppresses the sales volume of injector units and impedes broader market penetration in price-sensitive geographies.

Market Trends

A key trend in the market is the focus on eco-friendly and waste-minimizing component design, driven by the healthcare sector's need to reduce environmental impact and manage supply chain risks. Manufacturers are increasingly moving away from traditional single-use disposable systems in favor of advanced syringeless and multi-patient consumable workflows. This transition is designed to significantly lower the volume of medical-grade plastic waste and minimize unused contrast media, addressing both ecological concerns and frequent iodine supply shortages. This commitment to sustainability has become a competitive standard; Bracco's 'Sustainability Report 2024' noted that its responsible manufacturing efforts earned an EcoVadis Platinum Medal, placing it in the top 1% of sustainable companies globally and validating the industry's growing emphasis on green technology.

Concurrently, the integration of AI algorithms is transforming injectors from simple delivery mechanisms into intelligent, interconnected diagnostic nodes. This trend extends beyond basic connectivity by embedding deep learning models directly into the imaging ecosystem to enhance image reconstruction, enabling reduced contrast volumes without sacrificing diagnostic quality. This technological evolution is supported by a commercial landscape where software enhancements are becoming as valuable as the hardware itself. The scale of this digital shift is illustrated by recent data; Bayer's December 2024 'RSNA 2024' press release reported that the global medical imaging AI sector generated sales exceeding $734 million in 2023, signaling a rapid expansion of the digital infrastructure that modern contrast delivery systems are now utilizing to optimize clinical outcomes.

Key Market Players

  • Bracco S.p.A.
  • Guerbet AG (Guerbet Group)
  • Medtron AG
  • GE HealthCare Technologies Inc.
  • Bayer Healthcare LLC
  • NemotoKyorindo Co., Ltd
  • ulrich GmbH & Co. Kg
  • Sino Medical-Device Technology Co., Ltd.
  • APOLLO RT Co. Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd.

Report Scope

In this report, the Global High Pressure Contrast Media Injectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

High Pressure Contrast Media Injectors Market, By Product

  • Injector Systems
  • Consumables
  • Syringes
  • Tubing
  • Others

High Pressure Contrast Media Injectors Market, By Type

  • Single Head Injectors
  • Dual Head Injectors
  • Syringeless Injectors

High Pressure Contrast Media Injectors Market, By Application

  • Interventional Cardiology
  • Interventional Radiology
  • Endovascular Surgery
  • Interventional Neuroradiology

High Pressure Contrast Media Injectors Market, By End Use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

High Pressure Contrast Media Injectors Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global High Pressure Contrast Media Injectors Market.

Available Customizations:

Global High Pressure Contrast Media Injectors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global High Pressure Contrast Media Injectors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Injector Systems, Consumables, Syringes, Tubing, Others)
    • 5.2.2. By Type (Single Head Injectors, Dual Head Injectors, Syringeless Injectors)
    • 5.2.3. By Application (Interventional Cardiology, Interventional Radiology, Endovascular Surgery, Interventional Neuroradiology)
    • 5.2.4. By End Use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America High Pressure Contrast Media Injectors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States High Pressure Contrast Media Injectors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada High Pressure Contrast Media Injectors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico High Pressure Contrast Media Injectors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Use

7. Europe High Pressure Contrast Media Injectors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany High Pressure Contrast Media Injectors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Use
    • 7.3.2. France High Pressure Contrast Media Injectors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom High Pressure Contrast Media Injectors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy High Pressure Contrast Media Injectors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain High Pressure Contrast Media Injectors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Use

8. Asia Pacific High Pressure Contrast Media Injectors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China High Pressure Contrast Media Injectors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Use
    • 8.3.2. India High Pressure Contrast Media Injectors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan High Pressure Contrast Media Injectors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea High Pressure Contrast Media Injectors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia High Pressure Contrast Media Injectors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End Use

9. Middle East & Africa High Pressure Contrast Media Injectors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia High Pressure Contrast Media Injectors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE High Pressure Contrast Media Injectors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa High Pressure Contrast Media Injectors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Use

10. South America High Pressure Contrast Media Injectors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil High Pressure Contrast Media Injectors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia High Pressure Contrast Media Injectors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina High Pressure Contrast Media Injectors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global High Pressure Contrast Media Injectors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Bracco S.p.A.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Guerbet AG (Guerbet Group)
  • 15.3. Medtron AG
  • 15.4. GE HealthCare Technologies Inc.
  • 15.5. Bayer Healthcare LLC
  • 15.6. NemotoKyorindo Co., Ltd
  • 15.7. ulrich GmbH & Co. Kg
  • 15.8. Sino Medical-Device Technology Co., Ltd.
  • 15.9. APOLLO RT Co. Ltd.
  • 15.10. Shenzhen Seacrown Electromechanical Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer